Skip to main content

Table 3 Plasma glucose and insulin concentrations during ipGTT with deuterated glucose

From: Effects of low-stearate palm oil and high-stearate lard high-fat diets on rat liver lipid metabolism and glucose tolerance

 

CON (n = 11)

HFP (n = 11)

HFL (n = 11)

Fasting glucose (mM)

5.7 ± 0.4

8.0 ± 0.5 **

7.7 ± 0.3 **

AUCg (mM · h)

15.3 ± 0.5

22.5 ± 0.7 ***

25.6 ± 0.8 ***,††

Fasting insulin (pM)

163 ± 23

438 ± 82 **

463 ± 34 ***

AUCi (pM · h)

670 ± 65

1622 ± 208 ***

1421 ± 112 **

AUCg*AUCi (mM · h*pM · h)

9138 ± 689

41146 ± 6721 ***

36262 ± 2635 **

HOMA-IR

33.8 ± 4.8

134.8 ± 24.3 **

171.0 ± 13.3 ***

2H2-glucose concentrations (n = 6 per diet group)

2 · AUCd2g (mM · h)

6.0 ± 1.0

9.6 ± 0.9 *

9.1 ± 2.5

AUCEN (% 2H2-glucose · h)

36.2 ± 4.9

37.5 ± 0.9

34.3 ± 1.0

Maximal EN (% 2H2-glucose)

22.6 ± 2.8

23.2 ± 0.7

20.9 ± 0.6

Time to maximal EN (min)

46.8 ± 4.2

52.8 ± 2.2

58.4 ± 1.6 *

  1. Data are expressed as mean ± SEM. CON, normal chow control diet; HFP, high-fat palm oil diet; HFL, high-fat lard diet; AUCg, area under the glucose curve; AUCi, area under the insulin curve; HOMA-IR, homeostatic model assessment for insulin resistance; AUCd2g, area under the 2H2-glucose curve (a factor 2 is necessary for comparison of area under the 2H2-glucose curve to area under the glucose curve because the glucose injected was only 50 % enriched in 2H2-glucose); EN, glucose enrichment (% 2H2-glucose of total glucose); AUCEN, area under the EN curve. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. CON; †† p < 0.01 vs. HFP